Friday, August 3, 2012

Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call

...continued

URL: http://www.investorpoint.com/news/INTHPINK/53280707/

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)